Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive Therapy

NCT01910532 is registered in ClinicalTrials.gov with Mario Ammirati as lead sponsor.

NCT NCT01910532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01910532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive Therapy
Lead sponsor
Mario Ammirati
Phase
Phase 4
Overall status
Withdrawn
Start date
April 30, 2010
Completion date
November 30, 2012
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension